MRNA’s claim to fame is delivering therapies and vaccines via mRNA. I’ll go out on a limb and predict that buyers of this IPO who hold for a year will lose money.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.